If so, consider the Horizon-HO clinical research study for adolescents and adults with hypothalamic obesity. If you have hypothalamic obesity or know someone who does, you probably know how difficult it can be to manage the extreme hunger and low energy levels that are often symptoms of hypothalamic obesity.
The Horizon-HO study is testing whether the study drug, Tesomet, can help people with hypothalamic obesity have a healthier body weight.
Click below to learn more or to find out if you or someone you know may qualify.
.svg){kind=small}
.svg){kind=small}